Experimental evidence for the age dependence of tau protein spread in the brain
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
We observed enhanced tau spreading in the aging mouse brain and tau misfolding in brain regions vulnerable in Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Enhanced neuron-to-neuron propagation of mutant P301Ltau in vivo. (A) Schematic showing the AAV sequence, the mRNA, and the proteins encoded in AAV CBA.eGFP.2a.huTau (WTtau and P301Ltau), as well as the tau protein propagation principle and detection methodology. Using a self-cleaving 2a peptide, transduced “donor” neurons express both eGFP and human tau as individual proteins. The propagation of tau can be visualized by immunofluorescence labeling of postmortem brain sections or fixed neurons in culture: Human tau detected in “recipient” neurons that do not express the fluorescence transduction marker eGFP indicates the propagation of tau between cells. Thereby, the upstream location of the GFP transduction marker prevents the detection of false positives that could occur due to incomplete translation of the mRNA. (B) Schematic for the unilateral injection of AAV eGFP-2a-huTau into the EC (green) and the experimental work flow. The location of the EC, the HPC (and subregion CA1), and the dentate gyrus (DG) in horizontal mouse brain sections is indicated. (C) Example of the immunofluorescence labeling of human tau (red) and GFP (green) in a horizontal brain section of a GFP-2a-WTtau–injected mouse with many huTau recipient cells: [huTau+/GFP−] cells, which received tau by cell-to-cell propagation (white arrowheads in close-ups 1 and 2), can be seen adjacent to the EC injection side (1) and in synaptic connected area CA1 (2). Cells transduced with the AAV (GFP+) can, in this specific case, be found in the EC and CA3. (D) Quantification of tau propagation (no. of recipient cells/no. of transduced cells) was done by counting all recipient (huTau+, red) and donor neurons (GFP+, green) in the entire ipsilateral EC and HPC formation (dashed white line). A higher propagation (P = 0.0472) was detected for P301Ltau compared to WTtau. (E) Scatterplot shows the average of recipient versus donor cells per mouse. Mean ± SEM, n = 3 animals per group and n = 4 to 5 brain sections per animal; single data points represent the mean per animal; unpaired two-tailed Student’s t test with Welch’s correction.](https://figures.cochat.ai/paper-figures/0d31dc33f7054e8d8166fe997bc5836c/experimental-evidence-for-the-age-dependence-of-tau-protein-spread-in-the-brain-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A newly developed model of tau spread has been described recently that utilizes an adeno-associated virus (AAV) and allows reliable discrimination of neurons that have been transduced to express human tau (hTau) versus neurons that receive hTau protein through spread19.”
From LRP1 is a master regulator of tau uptake and spread (2020) · cites this paper as [19]
In the citing paper
“Progressive supranuclear palsy (PSP) is another form of tauopathy commonly observed in individuals around their mid-60 years. Its prevalence notably increases with advancing age, often manifesting more prominently in those aged 70 years and older. This condition is characterized by the progressive accumulation of the tau protein in the brain, which becomes more prevalent with advancing age.26”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Self-citationStaging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591
Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427
Self-citationArnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
Self-citationSzymczak, A. L., Workman, C. J., Wang, Y., Vignali, K. M., Dilioglou, S., Vanin, E. F., & Vignali, D. A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt957 · Cited by 1,059
Trans-Synaptic Spread of Tau Pathology In Vivo
Liu, L., Drouet, V., Wu, J. W., Witter, M. P., Small, S. A., Clelland, C., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 1,002
Neuronal activity enhances tau propagation and tau pathology in vivo
Wu, J. W., Hussaini, S. A., Bastille, I. M., Rodriguez, G. A., Mrejeru, A., Rilett, K., Sanders, D. W., Cook, C., Fu, H., Boonen, R. A. C. M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4328 · Cited by 820
Cited by
Items 101–143 of 143
Age dependent trans-cellular propagation of human tau aggregates in Drosophila disease models
Aqsa, A., & Sarkar, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147207 · Cited by 7
Kosa, A., Lopez‐Gutierrez, L., Ando, K., Doeraene, E., Aydin, E., Lasri, H., Wathelet‐Depauw, A., Pieters, K., Morckhoven, D. V., Imbault, V., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70784 · Cited by 6
Cekała, K., Trepczyk, K., Witkowska, J., Jankowska, E., & Wieczerzak, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094663 · Cited by 6
LRP1 and SORL1 regulate tau internalization and degradation and enhance tau seedingPreprint
Cooper, J. M., Lathuilière, A., Migliorini, M. M., Arai, A. L., Wani, M. M., Dujardin, S., Muratoglu, S. C., Hyman, B. T., & Strickland, D. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.17.386581 · Cited by 6
Self-citationDickson, J. R., Sobolewski, R. G. R., Fernandes, A. R., Cooper, J. M., Fan, Z., Chung, M., Donahue, C., Oakley, D. H., Strickland, D. K., & Hyman, B. T. (2025) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaf007 · Cited by 6
Self-citationRate of tau propagation is a heritable disease trait in genetically diverse mouse strains
Welikovitch, L. A., Dujardin, S., Dunn, A. R., Fernandes, A. R., Khasnavis, A., Chibnik, L. B., Kaczorowski, C. C., & Hyman, B. T. (2023) · iScience · doi:10.1016/j.isci.2023.105983 · Cited by 7
Self-citationSadeghzadeh, J., Jafarzadeh, J., Hadinezhad, P., Nazari, A., Sohrabi, S., Musazadeh, V., Barzegar, A., & Shahabi, P. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110314 · Cited by 6
Differences in Tau Seeding in Newborn and Adult Wild-Type Mice
Ferrer, I., Andrés‐Benito, P., Garcia‐Esparcia, P., López‐González, I., Valiente, D., Jordán, M., Carmona, M., Sala‐Jarque, J., Gil, V., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094789 · Cited by 8
Evidence for trans-synaptic propagation of oligomeric tau in Progressive Supranuclear PalsyPreprint
McGeachan, R. I., Keavey, L., Rose, J. L., Simzer, E. M., Chang, Y. Y., Spires-Jones, M. P., Gilmore, M., Ravingerova, N., Scutariu, C., Taylor, L. W., et al. (2022) · medRxiv · doi:10.1101/2022.09.20.22280086 · Cited by 5
A Novel Phosphorylated Tau Conformer Implicated in the Tauopathy Pathogenesis of Human Neurons
Tofigh, N., Agahi, S., Riazi, G. H., Pakdaman, H., Moazzam, M. G., & Shahpasand, K. (2025) · Biomolecules · doi:10.3390/biom15040585 · Cited by 4
Drosophila appear resistant to trans-synaptic tau propagation
Catterson, J. H., Mouofo, E. N., Soler, I. L. D. T., Lean, G., Dlamini, S., Liddell, P., Voong, G., Katsinelos, T., Wang, Y., Schoovaerts, N., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae256 · Cited by 5
Pérez-Rando, M., Dujardin, S., Bennett, R. E., Commins, C., Nibhanupudy, T. J., & Hyman, B. T. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01049-7 · Cited by 4
Self-citationEllingford, R. A., Harris, S., Kehring, M., Rajani, R. M., Lam, F. K. W., Graykowski, D. R., Böken, D., Welikovitch, L. A., Khasnavis, A., Laban, R., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.027 · Cited by 8
Self-citationBjorkli, C., Hemler, M. E., Julian, J. B., Sandvig, A., & Sandvig, I. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.913971 · Cited by 5
Duwat, C., Léal, P., Vautheny, A., Aurégan, G., Joséphine, C., Gaillard, M., Hérard, A., Jan, C., Gipchtein, P., Mitja, J., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106116 · Cited by 7
Tau Pathology in Neurodegenerative Diseases
Vogels, T., & Hromádka, T. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_4 · Cited by 2
Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathologyPreprint
Saroja, S. R., Gorbachev, K., Julia, T. C. W., Goate, A., & Pereira, A. C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.07.451493 · Cited by 3
Pathological tau alters head direction signaling and induces spatial disorientation
Jiang, S., Hijazi, S., Sárkány, B., Gautsch, V. G., LaChance, P. A., Hasselmo, M. E., Bannerman, D. M., & Viney, T. J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116610 · Cited by 6
Wang, X., Ye, T., Dai, B., Zhang, J., Zhou, W., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251406131 · Cited by 3
Huang, R., Ye, X., Liu, J., Yang, C., Meng, X., Dou, T., Zhuang, X., Yang, J., Zheng, N., Zhao, Y., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108265 · Cited by 2
Influence of Host Age on Intracranial AAV9 TauP301L Induced Tauopathy
Tetlow, A. M., Jackman, B. M., Alhadidy, M. M., Perumal, V., Morgan, D., & Gordon, M. N. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221276 · Cited by 2
Wu, Q., Mao, W.-Y., Gao, Y., Wen, Z.-P., Chen, B., Zhang, J., Xu, Y. J., & Liu, S. (2025) · Depression and Anxiety · doi:10.1155/da/9633212 · Cited by 2
Sivanesan, S., Howell, M. D., Kaushik, V., Rajadas, J., Pari, S. S., & Goyal, P. (2024) · Current Alzheimer Research · doi:10.2174/0115672050324909240823104209 · Cited by 1
An autophagy adaptor TRIAD3A promotes tau fibrillation by phase separation
Zhou, J., Chuang, Y. ‘., Redding-Ochoa, J., Platero, A. J., Barrett, A. H., Troncoso, J. C., Worley, P. F., & Zhang, W. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.095036 · Cited by 1
APOE4 exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction
Yu, Q., Du, F., Puerta-Alvarado, V., Goodman, J. H., & Waites, C. L. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08543-1 · Cited by 4
Kara, E., Crimi, A., Wiedmer, A. E., Emmenegger, M., Manzoni, C., Bandrés‐Ciga, S., D’Sa, K., Reynolds, R. H., Botía, J. A., Losa, M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.23.886838
Self-citationP38 Initiates Diabetic Neurodegeneration Through Glutamatergic and GABAergic NeuronsPreprint
Farhadi, A., Totonchi, M., Nabavi, S. M., Baharvand, H., Pakdaman, H., Hajizadeh‐Saffar, E., Mousavi, A., Hadi, F., Sinawi, H. A., Li, Q., et al. (2020) · doi:10.21203/rs.3.rs-41603/v1
TREM2 Limits Progression of Deficits and Spreading of Tau Pathology in MicePreprint
Feiten, A., Au, C. G., van Hummel, A., van der Hoven, J., Deng, Y., Przybyla, M., Bright, F., Butler, T. A., Delerue, F., Toutonji, A., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-741896/v1
Self-citationChanges in Organ Systems over the Lifespan
Tan, B. L., & Norhaizan, M. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-82859-2_2 · Cited by 1
Alzheimer’s Disease: A Neurodegenerative Menace of Elderly
Balwan, W. K., & Saba, N. (2021) · Scholars Academic Journal of Biosciences · doi:10.36347/sajb.2021.v09i05.001
Zhang, Y., Yang, Y., Hu, Z., Zhu, M., Qin, S., Peng, Y., Li, B., Xu, J.-T., Rowan, M., & Hu, N.-W. (2022) · bioRxiv · doi:10.1101/2022.03.28.486022
Faculty Opinions recommendation of LRP1 is a master regulator of tau uptake and spread.
Schiavo, G., & Moretto, E. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737661382.793574111
TREM2 limits progression of deficits and spreading of tau pathology in micePreprint
Feiten, A., Au, C. G., Sabale, M., van Hummel, A., van der Hoven, J., Deng, Y., Przybyla, M., Bright, F., Butler, T., Delerue, F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-741896/v2
Self-citationManosilp, W., Phathong, S., & Keerativoranant, S. (2023) · International Journal of Current Science Research and Review · doi:10.47191/ijcsrr/v6-i7-44
A Novel Pathogenic Tau Conformer Playing Part in Tau Pathology in Human Neurons Upon Aging StressPreprint
Tofigh, N., Agahi, S., Riazi, G. H., Pakdaman, H., Moazzam, M. G., & Shahpasand, K. (2023) · Research Square · doi:10.21203/rs.3.rs-3355775/v1
Astrocytic tau inclusions lead to microglial abnormalities, but leave neuronal networks intactPreprint
Vogels, T., Vargová, G., & Hromádka, T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.28.577642
Disease-specific tau polymorphs define unique protein interaction networks across proteinopathiesPreprint
Puangmalai, N., Bhatt, N. N., Suthprasertporn, N., Miranda-Morales, E. G., Shchankin, N., Samples, M., Balci, A. E., Liew, J. Y., Montalbano, M., Zhao, Y., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.09.675096
Cai, Y., Du, J., Li, A., Zhu, Y., Xu, L., Sun, K., Ma, S., & Guo, T. (2024) · Figshare · doi:10.6084/m9.figshare.26567042
High-Throughput Screening Identifies Small- Molecule Inhibitors of the Tau-LRP1 InteractionPreprint
Wang, C., Ma, C.-T., Crotty, C., Zeng, F., Bobkov, A. A., Covel, J. A., Rivera, E. K., Sergienko, E. A., Kosik, K. S., Olson, S. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.24.733881
Disease-specific tau polymorphs are associated with unique protein networks across proteinopathies
Puangmalai, N., Bhatt, N. N., Suthprasertporn, N., Miranda-Morales, E. G., Shchankin, N., Samples, M., Balci, A. E., Liew, J. Y., Montalbano, M., Zhao, Y., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00897-8
Guruacharya, A., Härtung, T., dos Reis, R. S., Moreira, N. C. D. S., Attisano, L., Bolognin, S., Iqbal, K., & Rajbanshi, B. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103051
High-Throughput Screening Identifies Small-Molecule Inhibitors of the Tau-LRP1 Interaction
Wang, C., Ma, C.-T., Crotty, C., Zeng, F.-Y., Bobkov, A., Covel, J. A., Rivera, E. K., Sergienko, E., Kosik, K. S., Olson, S. H., et al. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00599
Metadata
- Authors
- Wegmann, S., Bennett, R. E., Delorme, L., Robbins, A. B., Hu, M., MacKenzie, D., Kirk, M. J., Schiantarelli, J., Tunio, N., Amaral, A. C., Fan, Z., Nicholls, S., Hudry, E., & Hyman, B. T.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Corresponding author
- Wegmann, Susanne
- Hyman, Bradley T.
- ORCID
- Venue
- Science Advances
- Published
- 2019-06
- Volume
- 5
- Issue
- 6
- Pages
- eaaw6404-eaaw6404
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC6594764
- OpenAlex
- W2953812575
- Cited by
- 144
- References
- 39
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 21 · 2023: 27 · 2022: 20 · 2021: 23 · 2020: 23 · 2019: 2
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DZNE Pub (publishedVersion, other-oa)
- Funders
- National Institute on Aging
- Ruth K. Broad Biomedical Research Foundation
- Massachusetts General Hospital
- Deutsches Zentrum für Neurodegenerative Erkrankungen
- Bright Focus Foundation
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- tau protein, Alzheimer's disease, tau misfolding, tau spread, age-related risk, entorhinal cortex, hippocampus, striatum, regional vulnerability, tau tangles, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cell Line, Disease Models, Animal, Female, Humans, Male, Mice, Inbred C57BL, Mice, Transgenic, Neurons, tau Proteins, Disease Progression, Mice, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.